Press release
Vasomotor Symptoms of Menopause Market Research Report by Geographical Analysis and Forecast to 2024
Global Vasomotor Symptoms of Menopause Market: OverviewMenopause is the stage during which women stop producing ovaries and there is an end of the fertile phase. It occurs in 85% of premenopausal women during their late 40s, resulting in the cessation of their menstrual cycle. Due to the cessation of menstrual flow, the production of estrogen decreases and gonadotropin increases, which gives rise to various physiological and psychological changes, called vasomotor symptoms. Vasomotor symptoms of menopause are the actions which are related to nerves and muscles that cause the blood vessels to dilate. Vasomotor symptoms of menopause are basically a transition between two phases: perimenopause and menopause. The major vasomotor symptoms associated with menopause are listed below:
Hot flashes:
Hot flash is one of the most frequent symptoms of menopause. During this condition, women feel enormous intensity of heat accompanied with excessive sweating. Hot flashes with sweating also occur at night and the condition is termed as night sweats which disturbs the sleep pattern of an individual.
Formication:
Formication is basically a form of paresthesia which results in an abnormal skin sensation, illusion or hallucination that some insects are crawling over the skin. It causes feelings of itchiness, tingling or even burning on the skin.
Migraine:
Due to the hormonal fluctuations of menstrual cycle, migraine headaches pose a serious impediment to women undergoing menopausal phase. They are a form of recurrent headaches that can last from few hours up to three days.
Dysfunctional uterine bleeding:
Due to abrupt changes in hormonal levels, ovulation becomes inconsistent causing endometrial hyperplasia to develop and result in abnormal bleeding.
Psychological symptoms:
There are a number of psychological symptoms associated with onset of menopause such as fatigue, anxiety, irritability, mood swings, insomnia etc.
Global Vasomotor Symptoms of Menopause Market: Segmentation
There are various therapies related to vasomotor symptoms of menopause and henceforth the market can be segmented as follows:
Hormone Replacement Therapy (HRT):
HRT is a hormone therapy which is given to women whose estrogen and progesterone hormone level have dropped enormously
Selective estrogen receptor modulators (SERM):
SERMs are a type of drugs that block the effect of estrogen in the breast cells and activate the action of estrogen in other cells such as uterine cells
Gabapentin:
They are a type of medications which reduces the effect of hot flash and night sweats
Antidepressants:
Few vasomotor symptoms are relieved with the aid of antidepressants. Example: fluoxetine and venlafaxine.
The driving factors that will augment the growth of menopausal symptoms therapeutics market are introduction of new treatments and therapies in the market, increasing awareness among female patients about their health and use of non-hormonal therapies.
Browse full report on Vasomotor Symptoms of Menopause Market -
http://www.transparencymarketresearch.com/vasomotor-symptoms-menopause-market.html
Global Vasomotor Symptoms of Menopause Market: Geographical Dynamics
Geographically, North America dominates the menopause therapeutics market followed by Europe. According to NutritionMD, about 40% of North American women seek treatment for menopausal symptoms. Increasing cases of menopausal symptoms and the rising need of women population to go for novel therapies are the major factors, which have driven the growth of the menopausal symptoms therapeutic market. Asia-Pacific is one of the most rapidly developing region and the prime factors that will drive the growth of menopausal symptoms therapeutics market in this region are increasing geriatric female population with menopause disorders, and a shift in preference from hormonal therapies to non-hormonal therapies that will create an opportunity for many pharmaceutical companies to develop novel technologies and therapies.
Global Vasomotor Symptoms of Menopause Market: Company Profiles
Some of the top market players of this market are Eli Lilly and Company. Procter & Gamble, Pfizer Inc., Ausio harmaceuticals, LLC, EndoCeutics, Inc., Edgemont Pharmaceuticals, LLC and many others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Request for brochure of this report -
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15731
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vasomotor Symptoms of Menopause Market Research Report by Geographical Analysis and Forecast to 2024 here
News-ID: 436390 • Views: …
More Releases from Transparency Market Research - Healthcare IT

Healthcare Information Systems Market - Increasing Government Funding for Health …
The leading players in the global healthcare information systems market are Cerner Corporation, McKesson, and All Scripts. Collectively, these players held a share of 26% in the global market in 2015, states Transparency Market Research. The diversified portfolio of these companies is expected to help them maintain a lead in the coming years. Several companies in the global healthcare information systems market are expected to focus on increasing geographical presence…

Healthcare Automation Market - Therapeutic Automation Remains Dominant Technolog …
Transparency Market Research (TMR) states that Siemens AG, General Electric Company, Swisslog Holding AG, and Koninklijke Philips N.V. are some of the leading companies in the global healthcare automation market. These players have consistently worked toward expansion of product portfolio and reinforcing business through innovation product development. In the coming years, to beat the competition, players are expected to plan for mergers and acquisitions to expand their horizons to newer…

Technology Spending on Revenue Cycle Management Market - APAC Grows Stronger in …
McKesson Corporation, Allscripts, Cerner Corporation, and Optum Health, Inc. were the leading players in the global market for technology spending on revenue cycle management in 2015. These key companies show the common strengths in having built strong distribution channels and effective long-term partnerships.
Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17597
According to a research report released by Transparency Market Research, technology spending on revenue cycle management is expected to experience a buildup in competitive rivalries…

Smart Healthcare Products Market: Integration of IoT and Big Data with Smart Hea …
The global smart healthcare products market is fragmented due to presence of high number of players who offer differentiated products. This allows players to focus on specific product types thus increasing their market presence. For instance, in 2014, Becton Dickinson & Company and Medtronic again were among leading vendors in smart syringes, Medtronic and Olympus Corporation led the smart pills sales, and Epic Systems Corporation and Allscripts Healthcare Solutions were…
More Releases for Vasomotor
Menopausal Population Growth Fuels Expansion Of Vasomotor Menopausal Symptoms Tr …
Which drivers are expected to have the greatest impact on the over the vasomotor menopausal symptoms (vms) treatment market's growth?
The rise in the population of menopausal women is predicted to drive the vasomotor menopausal symptom's treatment market expansion. Menopause, a natural system marking the conclusion of reproductive years in a woman, typically takes place between the ages of 45 and 55, with the average age being roughly 51. The increase…
Vasomotor Symptoms Market Trends, Size, Share & Forecast
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Vasomotor Menopausal Symptoms (VMS) Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $23.11 billion…
The Comprehensive Guide to the Vasomotor Symptoms Treatment Market
Welcome to our comprehensive exploration of the Vasomotor Symptoms Treatment Market, a rapidly evolving sector within healthcare. In this extensive article, we will provide a detailed analysis of various aspects of this market, including its overview, dynamics, external trends, segmentation, growth drivers, recent developments, hydrogel dressing analysis, competitor landscape, key players, and an extensive list of frequently asked questions (FAQs).
Get a Free Sample Report with a Table of Contents@ https://www.expertmarketresearch.com/reports/vasomotor-symptoms-treatment-market/requestsample
Vasomotor Symptoms…
Vasomotor SymptomsTherapeutics: Unveiling New Drug Prospects and Market Predicti …
The Estetrol market forecast report provides analysis of Estetrol market analysis and forecasts upto 2032 in the major markets. The comprehensive report provides analysis of Estetrol market potential and Estetrol market share analysis in Vasomotor Symptoms across the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan from 2019 to 2032. It helps you to understand the Estetrol mechanism of action, route of administration, dosage and…
Vasomotor Symptoms of Menopause Market to be at Forefront by 2024
Menopause is the stage during which women stop producing ovaries and there is an end of the fertile phase. It occurs in 85% of premenopausal women during their late 40s, resulting in the cessation of their menstrual cycle. Due to the cessation of menstrual flow, the production of estrogen decreases and gonadotropin increases, which gives rise to various physiological and psychological changes, called vasomotor symptoms. Vasomotor symptoms of menopause are…
Vasomotor Symptoms of Menopause Market Share by Industry Research 2016 - 2024
Global Vasomotor Symptoms of Menopause Market: Overview
Menopause is the stage during which women stop producing ovaries and there is an end of the fertile phase. It occurs in 85% of premenopausal women during their late 40s, resulting in the cessation of their menstrual cycle. Due to the cessation of menstrual flow, the production of estrogen decreases and gonadotropin increases, which gives rise to various physiological and psychological changes, called vasomotor…